NO20003059L - Transmukosale formuleringer av levosimendan - Google Patents

Transmukosale formuleringer av levosimendan

Info

Publication number
NO20003059L
NO20003059L NO20003059A NO20003059A NO20003059L NO 20003059 L NO20003059 L NO 20003059L NO 20003059 A NO20003059 A NO 20003059A NO 20003059 A NO20003059 A NO 20003059A NO 20003059 L NO20003059 L NO 20003059L
Authority
NO
Norway
Prior art keywords
levosimendan
patient
source
mucous membrane
transmucosal formulations
Prior art date
Application number
NO20003059A
Other languages
English (en)
Other versions
NO20003059D0 (no
NO320050B1 (no
Inventor
Kauko Kurkela
Martti Marvola
Ilkka Larma
Raimo Virtanen
Marianne Karlsson
Original Assignee
Orion Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Corp filed Critical Orion Corp
Publication of NO20003059D0 publication Critical patent/NO20003059D0/no
Publication of NO20003059L publication Critical patent/NO20003059L/no
Publication of NO320050B1 publication Critical patent/NO320050B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Otolaryngology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Paper (AREA)
  • Air Bags (AREA)
NO20003059A 1997-12-19 2000-06-14 Transmukosale formuleringer av levosimendan og anvendelse derav til fremstilling av faramasoytisk preparat. NO320050B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI974578A FI974578L (fi) 1997-12-19 1997-12-19 Menetelmä levosimendaanin antamiseksi
PCT/FI1998/000977 WO1999032081A1 (en) 1997-12-19 1998-12-11 Transmucosal formulations of levosimendan

Publications (3)

Publication Number Publication Date
NO20003059D0 NO20003059D0 (no) 2000-06-14
NO20003059L true NO20003059L (no) 2000-06-14
NO320050B1 NO320050B1 (no) 2005-10-17

Family

ID=8550178

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003059A NO320050B1 (no) 1997-12-19 2000-06-14 Transmukosale formuleringer av levosimendan og anvendelse derav til fremstilling av faramasoytisk preparat.

Country Status (26)

Country Link
US (1) US6399610B1 (no)
EP (1) EP1052973B1 (no)
JP (1) JP2001526205A (no)
KR (1) KR100753689B1 (no)
AT (1) ATE215358T1 (no)
AU (1) AU738082B2 (no)
BR (1) BR9813641A (no)
CA (1) CA2313618C (no)
CZ (1) CZ296693B6 (no)
DE (1) DE69804678T2 (no)
DK (1) DK1052973T3 (no)
EA (1) EA002197B1 (no)
EE (1) EE04330B1 (no)
ES (1) ES2175827T3 (no)
FI (1) FI974578L (no)
HR (1) HRP20000400B1 (no)
HU (1) HU226736B1 (no)
IL (1) IL136415A (no)
NO (1) NO320050B1 (no)
NZ (1) NZ504806A (no)
PL (1) PL191868B1 (no)
PT (1) PT1052973E (no)
RS (1) RS49889B (no)
SK (1) SK284838B6 (no)
WO (1) WO1999032081A1 (no)
ZA (1) ZA9811405B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI980901A7 (fi) * 1998-04-23 1999-10-24 Orion Yhtymae Oyj Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
FI20002755A0 (fi) 2000-12-15 2000-12-15 Orion Yhtymae Oyj Menetelmä erektiilin dysfunktion hoitamiseen
CN100428937C (zh) * 2003-10-30 2008-10-29 北京海合天科技开发有限公司 左西孟旦冷冻干燥组合物
FI20040674A0 (fi) * 2004-05-12 2004-05-12 Orion Corp Menetelmä tromboembolisten sairauksien estoon
EP2767163A1 (en) * 2005-02-17 2014-08-20 Abbott Laboratories Transmucosal administration of drug compositions for treating and preventing disorders in animals
US20070010518A1 (en) * 2005-02-18 2007-01-11 Matti Kivikko Method for administering levosimendan
WO2007096906A2 (en) * 2006-02-27 2007-08-30 Panacea Biotec Ltd. Novel buccoadhesive compositions and process of preparation thereof
KR20090055606A (ko) * 2006-09-27 2009-06-02 니코노범 에이비 지향성 용도
US11523986B2 (en) * 2019-03-22 2022-12-13 Dbbh, Llc Intranasally administered antihistamines and uses thereof
CA3145456A1 (en) * 2019-07-01 2021-01-07 Orion Corporation Methods for administering (r)-n-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]acetamide
JP2023507626A (ja) 2019-12-16 2023-02-24 テナックス・セラピューティクス，インコーポレイテッド 駆出率が保たれた心不全を伴う肺高血圧症（ＰＨ－ＨＦ－ｐＥＦ）を治療するためのレボシメンダン

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2251615B (en) * 1991-01-03 1995-02-08 Orion Yhtymae Oy (-)-[[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazono]pro panedinitrile
GB2266841A (en) * 1992-05-06 1993-11-17 Orion Yhtymae Oy Compounds for use as anti-ischemic medicaments
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
GB9614098D0 (en) 1996-07-05 1996-09-04 Orion Yhtymae Oy Transdermal delivery of levosimendan

Also Published As

Publication number Publication date
WO1999032081A1 (en) 1999-07-01
US6399610B1 (en) 2002-06-04
FI974578A7 (fi) 1999-06-20
DE69804678D1 (de) 2002-05-08
ZA9811405B (en) 1999-06-11
ATE215358T1 (de) 2002-04-15
IL136415A (en) 2005-03-20
EA200000686A1 (ru) 2000-12-25
NO20003059D0 (no) 2000-06-14
RS49889B (sr) 2008-08-07
HU226736B1 (en) 2009-08-28
SK284838B6 (sk) 2005-12-01
CA2313618A1 (en) 1999-07-01
EP1052973A1 (en) 2000-11-22
YU36900A (sh) 2003-02-28
NO320050B1 (no) 2005-10-17
BR9813641A (pt) 2000-10-17
NZ504806A (en) 2001-09-28
SK9062000A3 (en) 2000-12-11
KR100753689B1 (ko) 2007-08-30
KR20010033368A (ko) 2001-04-25
HRP20000400B1 (hr) 2009-06-30
EE04330B1 (et) 2004-08-16
DK1052973T3 (da) 2002-04-29
FI974578L (fi) 1999-06-20
EA002197B1 (ru) 2002-02-28
FI974578A0 (fi) 1997-12-19
HRP20000400A2 (en) 2000-12-31
PT1052973E (pt) 2002-09-30
DE69804678T2 (de) 2002-11-21
HUP0100452A3 (en) 2002-03-28
PL191868B1 (pl) 2006-07-31
PL341202A1 (en) 2001-03-26
ES2175827T3 (es) 2002-11-16
CZ296693B6 (cs) 2006-05-17
CA2313618C (en) 2008-02-05
AU738082B2 (en) 2001-09-06
AU1565699A (en) 1999-07-12
CZ20002155A3 (cs) 2000-11-15
EP1052973B1 (en) 2002-04-03
IL136415A0 (en) 2001-06-14
JP2001526205A (ja) 2001-12-18
HUP0100452A2 (hu) 2002-02-28
EE200000368A (et) 2001-10-15

Similar Documents

Publication Publication Date Title
NO964864D0 (no) Orale, flytende alendronatpreparater
AU1079701A (en) Oral transmucosal drug dosage using solid solution
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
EP0962225A3 (en) Use of phentolamine for the manufacture of a medicament for the treatment of erectile dysfunction
ATE264102T1 (de) Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption
ATE306931T1 (de) Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
WO1998035658A3 (de) Verwendung von 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzochinon
PT998287E (pt) Utilizacao de levobupivacaina
ATE388687T1 (de) Medikamentöse verabreichung von nikotin in form von kaugummi
NO20003059D0 (no) Transmukosale formuleringer av levosimendan
NO994257L (no) Anvendelse av levobupivakain ved ansiktskirurgi
MY114716A (en) Prophylactic and/or therapeutic treatment of dyspeptic symptoms
BR9306642A (pt) Preparado para o tratamento profilático e terapêutico das cáries
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
RU97115801A (ru) Способ лечения стенозирующих ларинготрахеитов у детей
MD1469G2 (ro) Metodă de tratament al şocului combustional
JPS59155318A (ja) 細胞の活性剤とその活用方法
MY117556A (en) Methods and formulations for modulating the human sexual response
RU97116821A (ru) Способ лечения респираторных заболеваний
UA41652A (uk) Спосіб лікування хворих на гіпертонічну хворобу
RU98112055A (ru) Способ лечения заболеваний слизистой оболочки рта у больных с вторичными иммунодефицитами
UA35948A (uk) Спосіб профілактики уражень слизової оболонки порожнини рота і губ
UA35918A (uk) Спосіб лікування червоного плескатого лишаю слизової оболонки порожнини рота

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees